Literature DB >> 31965786

Luminescence-Sensing Tb-MOF Nanozyme for the Detection and Degradation of Estrogen Endocrine Disruptors.

Li Wang1, Yang Chen1.   

Abstract

Using flexible structures and components of metal-organic framework (MOF) materials, we designed and developed an artificial nanozyme with dual functions of a catalyst and luminescent sensor specifically for the determination and degradation of hormone 17β-estradiol (E2) and its derivatives (E1, E3, and EE2), a class of disruptors with strong effect on the human endocrine system. This nanozyme composed of the luminescent Tb3+ ion, catalytic coenzyme factor hemin, and light-harvesting ligand can be used to both degrade E2 like natural horseradish peroxidase (HRP) and sense E2 as low as 50 pM by its luminescence. The nanozyme catalyzes the decomposition of E2 and its derivatives through a mechanism of active hydroxyl radicals and oxidative high-valent iron-oxo intermediates. The prepared nanozyme is pluripotent, stable, and cheap and can replace the widely used combination of natural enzyme and chromogenic substrate. The present strategy of constructing artificial enzymes directly from functional units provides a new way for the design and development of smart, multifunctional artificial enzymes.

Entities:  

Keywords:  17β-estradiol (E2); endocrine disruptor; fluorescence; lanthanide MOF (metal-organic framework); multifunctional enzyme; nanozyme (nanoenzyme)

Mesh:

Substances:

Year:  2020        PMID: 31965786     DOI: 10.1021/acsami.9b22537

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Development of hybrid monoliths incorporating metal-organic frameworks for stir bar sorptive extraction coupled with liquid chromatography for determination of estrogen endocrine disruptors in water and human urine samples.

Authors:  S Zatrochová; H Martínez-Pérez-Cejuela; M Catalá-Icardo; E F Simó-Alfonso; I Lhotská; D Šatínský; J M Herrero-Martínez
Journal:  Mikrochim Acta       Date:  2022-02-07       Impact factor: 5.833

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.